MAXYGEN INC Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-08-30: Form 8-K; Period of report 2013-08-29; Description 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 3.01.
- 2013-08-13: Form 8-K; Period of report 2013-08-12; Description 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events; Details 3.01.
- 2013-08-07: Form 8-K; Period of report 2013-08-07; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2013-06-03: Form 8-K; Period of report 2013-05-30; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events; Details 5.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2013-08-30 | 8-K | 2013-08-29 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 3.01 The disclosure set forth below under Item 3.03 with respect to the suspension and delisting of the common stock, $0.0001 par value per share (the “Common Stock”), of Maxygen, Inc. (the “Company”) from the NASDAQ Global Market is incorporated herein by reference. 3.03 As contemplated by the Plan of Complete Liquidation and Dissolution previously approved by the Company’s Board of Directors and stockholders (“Plan of Dissolution”), the Company has filed a certificate of dissolution (the “Certificate of Dissolution”) with the Secretary of State of the State of Delaware. 5.02 (b) As previously disclosed, on August 29, 2013, the effective date of the Certificate of Dissolution, the resignations of Louis Lange, Kenneth Lee, Ernest Mario and Gordon Ringold as members of the Company’s Board of Directors became effective. 8.01 On August 29, 2013, the Company issued a press release announcing the filing of the Certificate of Dissolution and other matters related to the Dissolution, a copy of which is included as exhibit 99.1 hereto and incorporated herein by reference. | d591659d8k.htm |
| 2013-08-13 | 8-K | 2013-08-12 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; 3.03 Material Modification to Rights of Security Holders; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 8.01 Other Events | 3.01 The disclosure set forth below under Item 3.03 with respect to the intention of Maxygen, Inc. (the “Company”) to delist its shares of Common Stock (as defined below) from the NASDAQ Global Market is incorporated herein by reference. 3.03 At the annual meeting of the stockholders of the Company held on August 12, 2013, the stockholders of the Company voted to approve the liquidation and dissolution of the Company pursuant to a Plan of Complete Liquidation and Dissolution (the “Plan of Dissolution”). 5.02 (b) In connection with stockholder approval of the dissolution of the Company, Louis Lange, Kenneth Lee, Ernest Mario and Gordon Ringold each tendered their resignation as members of the Company’s Board of Directors, which resignations will be effective upon the effective date of the Company’s certificate of dissolution. 5.07 The Company held its annual meeting of stockholders on August 12, 2013. 8.01 In connection with stockholder approval of the dissolution of the Company, the Company’s Board of Directors approved an initial liquidating distribution of $2.50 per share of Common Stock. | d581604d8k.htm |
| 2013-08-07 | 8-K | 2013-08-07 | 2.02 Results of Operations and Financial Condition | 2.02 On August 7, 2013, Maxygen, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2013. | d580926d8k.htm |
| 2013-06-03 | 8-K | 2013-05-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 On May 30, 2013, the Board of Directors (the “Board”) of Maxygen, Inc. (the “Company”) approved the dissolution and liquidation of the Company (the “Dissolution”) pursuant to a Plan of Complete Liquidation and Dissolution (the “Plan of Dissolution”), subject to stockholder approval. 8.01 On May 30, 2013, the Board approved the Dissolution pursuant to the Plan of Dissolution, subject to stockholder approval. | d547321d8k.htm |
| 2013-05-03 | 8-K | 2013-05-03 | 2.02 Results of Operations and Financial Condition | 2.02 On May 3, 2013, Maxygen, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2013. | d529024d8k.htm |
| 2013-03-12 | 8-K | 2013-03-12 | 2.02 Results of Operations and Financial Condition | 2.02 On March 12, 2013, Maxygen, Inc. issued a press release announcing its financial results for the quarter and year ended December 31, 2012. | d499150d8k.htm |